Clinical Validation of the Withings ECG Monitor for the Detection of Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 274 participants.
Also called NCT05266235
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 274 participants
- Sponsor
- Registry
-
NCT05266235
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, France
- Registry status
- Completed
Technical summary
Registry record NCT05266235. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-04-14 (actual); primary completion 2022-07-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Validation of the Withings ECG Monitor for the Detection of Atrial Fibrillation
- Acronym
- QDA-UE
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Validation of the Withings bodyscan scale WBS08
- Lead sponsor
- Withings
Record details
- Record id
cardio:ct-nct05266235- Content hash
da889bd18e1ac0ff01bbd543f26836fd5f4e0b3f220e0a7fc4f07a9364b6b4b2